Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1

Journal of Dermatological Science

Volumn 53, Issue 2, 2009, Pages 112-119

  Cedeno Laurent, Filiberto ^a   Bryant, Joseph ^a   Fishelevich, Rita ^a   Jones, Odell D ^a   Deng, April ^a   Eng, Maria L ^a   Gaspari, Anthony A ^a   Trujillo, J Roberto ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Erythema multiforme; HIV 1; Skin; Transgenic

Indexed keywords

CYTOKINE; GAG PROTEIN; IMMUNOGLOBULIN G ANTIBODY; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN NECROSIS; STRUCTURAL GENE; TH1 CELL; TH2 CELL; TRANSGENE; TRANSGENIC RAT; XEROSIS;

ANIMALS; CYTOKINES; DERMATITIS; DISEASE MODELS, ANIMAL; EPIDERMIS; ERYTHEMA MULTIFORME; GENOTYPE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HYPERPLASIA; NECROSIS; PHENOTYPE; RATS; RATS, TRANSGENIC; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SKIN ULCER; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 57649156378     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.08.015     Document Type: Article

References (38)

1. Zalla M.J., Su W.P., and Fransway A.F. Dermatologic manifestations of human immunodeficiency virus infection. Mayo Clin Proc 67 (1992) 1089-1108
2. Calista D., Morri M., Stagno A., and Boschini A. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 3 (2002) 59-62
3. Bernstein W.B., Little R.F., Wilson W.H., and Yarchoan R. Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol 84 (2006) 3-11
4. Maurer T.A. Dermatologic manifestations of HIV infection. Top HIV Med 13 (2005) 149-154
5. Uthayakumar S., Nandwani R., Drinkwater T., Nayagam A.T., and Darley C.R. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol 137 (1997) 595-598
6. Klotman P.E., and Notkins A.L. Transgenic models of human immunodeficiency virus type-1. Curr Top Microbiol Immunol 206 (1996) 197-222
7. Dickie P., Ramsdell F., Notkins A.L., and Venkatesan S. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 197 (1993) 431-438
8. Corallini A., Altavilla G., Pozzi L., Bignozzi F., Negrini M., Rimessi P., et al. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 53 (1993) 5569-5575
9. Vogel J., Hinrichs S.H., Reynolds R.K., Luciw P.A., and Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335 (1988) 606-611
10. Reid W., Sadowska M., Denaro F., Rao S., Foulke Jr. J., Hayes N., et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98 (2001) 9271-9276
11. Wei P., Garber M.E., Fang S.M., Fischer W.H., and Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92 (1998) 451-462
12. Breuer-McHam J.N., Ledbetter L.S., Sarris A.H., and Duvic M. Cytokine expression patterns distinguish HIV associated skin diseases. Exp Dermatol 9 (2000) 341-350
13. Arrigo S.J., Weitsman S., Rosenblatt J.D., and Chen I.S. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol 63 (1989) 4875-4881
14. Arrigo S.J., Weitsman S., Zack J.A., and Chen I.S. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol 64 (1990) 4585-4588
15. Kopp J.B., Rooney J.F., Wohlenberg C., Dorfman N., Marinos N.J., Bryant J.L., et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res Hum Retroviruses 9 (1993) 267-275
16. Klotman P.E., Rappaport J., Ray P., Kopp J.B., Franks R., Bruggeman L.A., et al. Transgenic models of HIV-1. AIDS 9 (1995) 313-324
17. Allan J.S., Coligan J.E., Barin F., McLane M.F., Sodroski J.G., Rosen C.A., et al. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228 (1985) 1091-1094
18. Trujillo J.R., Rogers R., Molina R.M., Dangond F., McLane M.F., Essex M., et al. Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. Proc Natl Acad Sci USA 104 (2007) 5097-5102
19. Brenneman D.E., McCune S.K., Mervis R.F., and Hill J.M. gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol 4 (1994) 157-165
20. Kapasi A.A., Patel G., Franki N., and Singhal P.C. HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation. Mol Med 8 (2002) 676-685
21. Chen F., Shannon K., Ding S., Silva M.E., Wetzel G.T., Klitzner T.S., et al. HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Res Hum Retroviruses 18 (2002) 777-784
22. Amendola A., Lombardi G., Oliverio S., Colizzi V., and Piacentini M. HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by 'tissue' transglutaminase expression and prevented by cyclosporin A. FEBS Lett 339 (1994) 258-264
23. Brown J.A., Howcroft T.K., and Singer D.S. HIV Tat protein requirements for transactivation and repression of transcription are separable. J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998) 9-16
24. Barillari G., and Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 15 (2002) 310-326
25. Poggi A., and Zocchi M.R. HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B. Clin Dev Immunol 13 (2006) 369-372
26. Buonaguro L., Barillari G., Chang H.K., Bohan C.A., Kao V., Morgan R., et al. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 66 (1992) 7159-7167
27. Gee K., Angel J.B., Mishra S., Blahoianu M.A., and Kumar A. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol 178 (2007) 798-807
28. Puri R.K., and Aggarwal B.B. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res 52 (1992) 3787-3790
29. Conaldi P.G., Bottelli A., Baj A., Serra C., Fiore L., Federico G., et al. Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 161 (2002) 53-61
30. Kim C.M., Vogel J., Jay G., and Rhim J.S. The HIV tat gene transforms human keratinocytes. Oncogene 7 (1992) 1525-1529
31. Altavilla G., Trabanelli C., Merlin M., Caputo A., Lanfredi M., Barbanti-Brodano G., et al. Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice. Am J Pathol 154 (1999) 1231-1244
32. Leonard J.M., Abramczuk J.W., Pezen D.S., Rutledge R., Belcher J.H., Hakim F., et al. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242 (1988) 1665-1670
33. Reid W., Abdelwahab S., Sadowska M., Huso D., Neal A., Ahearn A., et al. HIV-1 transgenic rats develop T cell abnormalities. Virology 321 (2004) 111-119
34. Maggi E., Manetti R., Annunziato F., Cosmi L., Giudizi M.G., Biagiotti R., et al. Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals. Blood 89 (1997) 3672-3681
35. Trujillo J.R., McLane M.F., Lee T.H., and Essex M. Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol 67 (1993) 7711-7715
36. Parmentier H.K., van Wichen D.F., Meyling F.H., Goudsmit J., and Schuurman H.J. Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. Am J Pathol 141 (1992) 1209-1216
37. Schuurman H.J., Joling P., van Wichen D.F., Tobin D., and van der Putte S.C. Epitopes of human immunodeficiency virus regulatory proteins tat, nef and rev are expressed in skin in atopic dermatitis. Int Arch Allergy Immunol 100 (1993) 107-114
38. Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S., Manzari V., et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94 (1999) 663-672